In India, the Russian-developed Corona Vaccine Sputnik V has been approved for emergency use. This is the third vaccine for the coronavirus to be approved after Kovshield (Serum Institute of India) and Kovaxin (Bharat Biotech).
The Sputnik V vaccine, developed by Moscow's Gamale National Research Institute of Epidemiology and Microbiology, uses two different viruses that cause the common cold (adenovirus) in humans. Adenovirus becomes weak so it cannot replicate in humans and cannot cause disease.
Let me tell you that this vaccine is also modified. For this reason, the vaccine provides a code for making the coronavirus spike protein. The purpose of this process is to ensure that when the actual virus tries to infect the body, it can mount an immune response in the form of antibodies.
Sputnik uses a different vector for each of the two shots during vaccination. According to this Russian Direct Investment Fund (RDIF), the same methods are used for both shots. It provides immunity with a longer duration than other vaccines. A difference of 21 days is required for both shots.
Sputnik V (liquid) is stored at a temperature of minus 18 ° C. However, its dried form can be stored at 2–8 ° C. This does not require investing in cold-chain infrastructure. According to the RDIF, Sputnik V has been approved for the use of more than 150 crore people in 55 countries. The vaccine is proposed to be priced below $ 10 per shot. Although its price in India has not been decided.
Dr. Reddy's labs based in Hyderabad sought government approval for the vaccine in India. RDIF partnered with Dr. Reddy's in September 2020 to conduct clinical trials in the country. On Monday, the Subject Expert Committee (SEC) of the Drugs Controller General of India took the Sputnik V application for Emergency Use Authority and moved on. DCGI previously sought additional data from the drug manufacturer.
Five other Indian companies have partnered with RDIF for Sputnik V. These include Gland Pharma, Hetero Biopharma, Virchow Biotech, Panacea Biotech, and Stellis Biopharma, Bangalore-based Strides Pharma Science's bioceramic. It is expected from their partnerships that India's capacity to manufacture this vaccine will exceed 60 million.
Prime Minister Narendra Modi today addressed a webinar on the topic "Energy for Sustainable Growt
Delhi Chief Minister Arvind Kejriwal's wife Sunita Kejriwal once again addressed the media. A cam
Raveena, who killed her husband Praveen along with her YouTuber lover Suresh Raghav, was not only
Pakistan is currently surrounded by a deep economic crisis. The country's foreign exchange reserv
The title match of the Champions Trophy will be played between India and New Zealand on March 9.
Maharashtra CET Cell will start the registration for MAH LLB Three Year CET 2022 CAP Round 2 from
After the fourth phase of voting in the Uttar Pradesh Assembly 2022 on Wednesday, now the next st
For the first time in Omicron's wave, there has been a decrease in death due to corona infection
Today is the third day of Prime Minister Narendra Modi's visit to Gujarat. Today he will hold pub
The Omicron variant of Corona could cause the third wave of the pandemic. This is to say that Pro
